Figure 1From: Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant Relationship between reduction in carbohydrate intake and improvement in glycaemic control (as indicated by change in HbA1c concentration) in rimonabant-treated subjects (n = 17) (r = 0.54, p < 0.05). Back to article page